The Surgical Optimal Mobility Score predicts mortality and length of stay in an Italian population of medical, surgical, and neurologic intensive care unit patients

Journal of Critical Care
Simone PivaNicola Latronico

Abstract

We validated the Italian version of Surgical Optimal Mobility Score (SOMS) and evaluated its ability to predict intensive care unit (ICU) and hospital length of stay (LOS), and hospital mortality in a mixed population of ICU patients. We applied the Italian version of SOMS in a consecutive series of prospectively enrolled, adult ICU patients. Surgical Optimal Mobility Score level was assessed twice a day by ICU nurses and twice a week by an expert mobility team. Zero-truncated Poisson regression was used to identify predictors for ICU and hospital LOS, and logistic regression for hospital mortality. All models were adjusted for potential confounders. Of 98 patients recruited, 19 (19.4%) died in hospital, of whom 17 without and 2 with improved mobility level achieved during the ICU stay. SOMS improvement was independently associated with lower hospital mortality (odds ratio, 0.07; 95% confidence interval [CI], 0.01-0.42) but increased hospital LOS (odds ratio, 1.21; 95% CI: 1.10-1.33). A higher first-morning SOMS on ICU admission, indicating better mobility, was associated with lower ICU and hospital LOS (rate ratios, 0.89 [95% CI, 0.80-0.99] and 0.84 [95% CI, 0.79-0.89], respectively). The first-morning SOMS on ICU admission pr...Continue Reading

References

Jun 12, 2004·Critical Care Medicine·Graeme RockerUNKNOWN Canadian Critical Care Trials Group
Apr 5, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Diane WildUNKNOWN ISPOR Task Force for Translation and Cultural Adaptation
Sep 24, 2005·Annals of Neurology·Eelco F M WijdicksRobyn L McClelland
Jul 4, 2008·Critical Care Medicine·Peter E MorrisEdward Haponik
Jul 23, 2009·Critical Care Medicine·Chris BurtinRik Gosselink
Apr 13, 2010·Archives of Physical Medicine and Rehabilitation·Dale M NeedhamEddy Fan
Nov 10, 2011·Critical Care Medicine·George KasotakisMatthias Eikermann
Apr 3, 2012·Journal of Neurosurgery·W Lee TitsworthJ Mocco
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Mar 27, 2013·Critical Care Medicine·Geetha KayambuJennifer Paratz
Oct 25, 2013·Intensive Care Medicine·Matthias Eikermann, Nicola Latronico
Jan 18, 2014·Current Physical Medicine and Rehabilitation Reports·Ann ParkerDale M Needham
Dec 17, 2014·American Journal of Respiratory and Critical Care Medicine·Eddy FanUNKNOWN American Thoracic Society
Jan 20, 2015·Critical Care Medicine·Nicola Latronico
Jul 15, 2015·Intensive Care Medicine·Nicola Latronico, Margaret S Herridge

❮ Previous
Next ❯

Citations

Feb 10, 2016·Journal of Critical Care·Stefan J SchallerManfred Blobner
Oct 7, 2016·Lancet·Stefan J SchallerUNKNOWN International Early SOMS-guided Mobilization Research Initiative
Feb 24, 2017·Annals of the American Thoracic Society·Peter NydahlDale M Needham
Oct 6, 2017·Critical Care : the Official Journal of the Critical Care Forum·Selina M ParryDale M Needham
Jan 20, 2018·Current Opinion in Anaesthesiology·Kristina Fuest, Stefan J Schaller
Jul 2, 2017·Der Anaesthesist·C J ReußT Brenner
Jan 23, 2019·Intensive Care Medicine·Stefan J SchallerMatthias Eikermann
Apr 10, 2019·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·Cynthia A BautistaDaiWai M Olson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.